Marek Brzosko Selected Research

Hyperostosis

1/2021	Serum interleukin-23 protects, whereas methotrexate treatment stimulates selected components of the metabolic syndrome in patients with SAPHO syndrome.
8/2016	Serum Interleukin-18, Fetuin-A, Soluble Intercellular Adhesion Molecule-1, and Endothelin-1 in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marek Brzosko Research Topics

Disease

10	Rheumatoid Arthritis 02/2019 - 09/2002
6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 01/2006
5	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 01/2021 - 01/2013
5	Inflammation (Inflammations) 01/2019 - 08/2004
5	Ankylosing Spondylitis 02/2017 - 05/2014
5	Psoriatic Arthritis 08/2016 - 01/2006
4	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2022 - 01/2019
4	Thrombosis (Thrombus) 01/2017 - 05/2006
4	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2016 - 01/2006
3	Anterior Uveitis 01/2022 - 01/2016
3	Arthritis (Polyarthritis) 01/2017 - 01/2007
2	Vasculitis (Vasculitides) 05/2022 - 01/2006
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2016
2	Axial Spondyloarthritis 01/2022 - 01/2017
2	Synovitis 01/2021 - 08/2016
2	Osteitis 01/2021 - 08/2016
2	Hyperostosis 01/2021 - 08/2016
2	Acne Vulgaris 01/2021 - 08/2016
2	Rheumatic Diseases (Rheumatism) 01/2018 - 05/2014
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2017 - 01/2013
2	Obesity 01/2017 - 01/2006
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2011 - 01/2006
2	Hypertension (High Blood Pressure) 01/2007 - 01/2006
2	Atherosclerosis 01/2007 - 01/2006
2	Myocardial Ischemia (Ischemic Heart Diseases) 05/2006 - 01/2006
2	Glucose Intolerance 05/2006 - 01/2006
2	Hypothyroidism 01/2006 - 01/2006
2	Pain (Aches) 01/2006 - 04/2005
1	Fever (Fevers) 01/2022
1	Ocular Hypertension (Glaucoma, Suspect) 01/2022
1	Ganglion Cysts (Ganglion) 01/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2021
1	Cachexia 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Amyloidosis 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2017
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 01/2017
1	Lupus Nephritis 01/2017
1	Thromboembolism 12/2016
1	Venous Thrombosis (Deep-Vein Thrombosis) 12/2016
1	Persian Gulf Syndrome (Gulf War Syndrome) 01/2016
1	Onycholysis 01/2016
1	Macrophagic myofasciitis 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Hemangioma (Angioma) 01/2012
1	Neoplasms (Cancer) 01/2011
1	Adult-Onset Still's Disease 09/2010

Drug/Important Bio-Agent (IBA)

10	AntibodiesIBA 12/2016 - 01/2006
6	Antiphospholipid AntibodiesIBA 01/2017 - 05/2006
4	CytokinesIBA 01/2021 - 01/2013
4	Interleukin-23 (Interleukin 23)IBA 01/2021 - 01/2015
4	AutoantibodiesIBA 01/2017 - 11/2009
3	C-Reactive ProteinIBA 01/2022 - 01/2019
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2015
3	Interleukin-18 (Interleukin 18)IBA 01/2022 - 01/2016
3	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 03/2011
3	Biosimilar PharmaceuticalsIBA 02/2019 - 02/2017
3	Infliximab (Remicade)FDA Link 02/2017 - 06/2004
3	tocilizumab (atlizumab)FDA Link 07/2016 - 03/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2016 - 01/2012
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 05/2022 - 05/2006
2	alpha-2-HS-GlycoproteinIBA 01/2022 - 08/2016
2	Biological ProductsIBA 01/2018 - 05/2014
2	Epidermal Growth Factor (EGF)IBA 03/2016 - 01/2013
2	Antinuclear AntibodiesIBA 01/2011 - 05/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2007 - 01/2004
2	Azathioprine (Imuran)FDA LinkGeneric 12/2006 - 05/2006
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 05/2006 - 01/2006
2	Immunoglobulin G (IgG)IBA 05/2006 - 08/2004
2	anti-endothelial cell antibodyIBA 05/2006 - 01/2006
2	Thyroid HormonesIBA 01/2006 - 01/2006
2	EnzymesIBA 01/2006 - 09/2002
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	SteroidsIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Calcium PyrophosphateIBA 07/2021
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 03/2021
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2021
1	CT-P10IBA 02/2019
1	Rituximab (Mabthera)FDA Link 02/2019
1	AntigensIBA 01/2019
1	tofacitinibIBA 01/2018
1	Janus KinasesIBA 01/2018
1	CT-P13IBA 02/2017
1	amsonic acid (DAS)IBA 01/2017
1	InterleukinsIBA 01/2017
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2017
1	enoxaparin sodium FDA LinkGeneric 12/2016
1	Endothelin-1 (Endothelin 1)IBA 08/2016
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2016
1	SiliconesIBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012
1	Prothrombin (Factor II)IBA 09/2010
1	Glycoproteins (Glycoprotein)IBA 09/2010

Therapy/Procedure

6	Therapeutics 01/2022 - 06/2004
1	Lasers (Laser) 01/2022
1	Tattooing 01/2016
1	Biological Therapy 05/2014